Endothelial cells derived from breast cancer vessels contain high levels of TRPV4, and inhibition of TRPV4 inhibits the stimulated migration of endothelial cells derived from breast cancer, suggesting that pharmacological inhibition of TRPV4 can inhibit angiogenesis (Fiorio Pla et al., 2012). The gene discussed is TRPV4; the disease is breast cancer.